Newsbenzinga
Lantern Pharma Announces EMA Clearance Of An Investigator-Initiated Phase 1b/2 Clinical Trial Of LP-184 In Advanced, Recurrent Bladder Cancer
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…